Literature DB >> 25637802

Dopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior.

M Y Wong1, A Borgkvist1, S J Choi1, E V Mosharov1, N S Bamford2, D Sulzer3.   

Abstract

Modulation of corticostriatal synaptic activity by dopamine is required for normal sensorimotor behaviors. After loss of nigrostriatal dopamine axons in Parkinson's disease, l-3,4-dihydroxyphenlalanine (l-DOPA) and dopamine D2-like receptor agonists are used as replacement therapy, although these drugs also trigger sensitized sensorimotor responses including dyskinesias and impulse control disorders. In mice, we lesioned dopamine projections to the left dorsal striatum and assayed unilateral sensorimotor deficits with the corridor test as well as presynaptic corticostriatal activity with the synaptic vesicle probe, FM1-43. Sham-lesioned mice acquired food equivalently on both sides, while D2 receptor activation filtered the less active corticostriatal terminals, a response that required coincident co-activation of mGlu-R5 metabotropic glutamate and CB1 endocannabinoid receptors. Lesioned mice did not acquire food from their right, but overused that side following treatment with l-DOPA. Synaptic filtering on the lesioned side was abolished by either l-DOPA or a D2 receptor agonist, but when combined with a CB1 receptor antagonist, l-DOPA or D2 agonists normalized both synaptic filtering and behavior. Thus, high-pass filtering of corticostriatal synapses by the coordinated activation of D2, mGlu-R5, and CB1 receptors is required for normal sensorimotor response to environmental cues.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Parkinson’s; corticostriatal; dopamine; l-DOPA; synapses

Mesh:

Substances:

Year:  2015        PMID: 25637802      PMCID: PMC4494866          DOI: 10.1016/j.neuroscience.2015.01.022

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  86 in total

1.  Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids.

Authors:  R G Pertwee; A P Wickens
Journal:  Neuropharmacology       Date:  1991-03       Impact factor: 5.250

Review 2.  The regulation of quantal size.

Authors:  W Van der Kloot
Journal:  Prog Neurobiol       Date:  1991       Impact factor: 11.685

3.  Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

Authors:  M Herkenham; A B Lynn; B R de Costa; E K Richfield
Journal:  Brain Res       Date:  1991-05-03       Impact factor: 3.252

4.  Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy.

Authors:  K K Yung; J P Bolam; A D Smith; S M Hersch; B J Ciliax; A I Levey
Journal:  Neuroscience       Date:  1995-04       Impact factor: 3.590

5.  Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity.

Authors:  M Morelli; S Fenu; L Garau; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1989-03-21       Impact factor: 4.432

6.  Both A1 and A2a purine receptors regulate striatal acetylcholine release.

Authors:  S J Brown; S James; M Reddington; P J Richardson
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

7.  Spontaneous firing patterns and axonal projections of single corticostriatal neurons in the rat medial agranular cortex.

Authors:  R L Cowan; C J Wilson
Journal:  J Neurophysiol       Date:  1994-01       Impact factor: 2.714

8.  6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death.

Authors:  B S Jeon; V Jackson-Lewis; R E Burke
Journal:  Neurodegeneration       Date:  1995-06

9.  Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

Authors:  H Sauer; W H Oertel
Journal:  Neuroscience       Date:  1994-03       Impact factor: 3.590

10.  Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.

Authors:  X T Hu; S R Wachtel; M P Galloway; F J White
Journal:  J Neurosci       Date:  1990-07       Impact factor: 6.167

View more
  5 in total

1.  The Striatum's Role in Executing Rational and Irrational Economic Behaviors.

Authors:  Ian J Bamford; Nigel S Bamford
Journal:  Neuroscientist       Date:  2019-01-24       Impact factor: 7.519

2.  Corticostriatal plasticity in the nucleus accumbens core.

Authors:  Nigel S Bamford; Wengang Wang
Journal:  J Neurosci Res       Date:  2019-07-12       Impact factor: 4.164

Review 3.  Dopamine's Effects on Corticostriatal Synapses during Reward-Based Behaviors.

Authors:  Nigel S Bamford; R Mark Wightman; David Sulzer
Journal:  Neuron       Date:  2018-02-07       Impact factor: 17.173

4.  Cue-Evoked Dopamine Release Rapidly Modulates D2 Neurons in the Nucleus Accumbens During Motivated Behavior.

Authors:  Catarina Owesson-White; Anna M Belle; Natalie R Herr; Jessica L Peele; Preethi Gowrishankar; Regina M Carelli; R Mark Wightman
Journal:  J Neurosci       Date:  2016-06-01       Impact factor: 6.167

Review 5.  The chemical tools for imaging dopamine release.

Authors:  Michael R Post; David Sulzer
Journal:  Cell Chem Biol       Date:  2021-04-23       Impact factor: 9.039

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.